Brand dynamics
Group Real-Time Dynamics And Cutting-Edge Information In The Field Of One Health
Time Posted：2019-08-06 19:18
Recently, the National Clinical Laboratory Center of the National Health Commission of China announced the results of the 2019 international inter-laboratory quality assessment of tumor circulating DNA (ctDNA) gene mutation detection. Lizhu Gene once again successfully passed with a perfect score!
Time Posted：2019-08-06 08:58
On May 31, 2019, the "Financial World 2019 Value Discovery Carnival, the Second China Enterprise Value Development Forum, and the 'Jinzhi Award' China Enterprise Value Selection Award Ceremony," hosted by Financial World, was grandly held in Shenzhen. Themed "Connecting Science and Technology Innovation, Connecting Sustainable Growth," the event invited leaders from relevant departments, 100 excellent listed companies, 100 institutional investors and industry support funds, and authoritative media, bringing together upstream and downstream resources of industrial development to connect ideas and resources, and unleash value and strength.
Time Posted：2019-06-06 09:10
The company's wholly-owned subsidiary, Tai Tai Pharmaceutical, has obtained new GMP certification for its non-hormonal liquid inhalation solution production line. This allows for the production and sale of inhalation compound ipratropium bromide solution. Inhalation compound ipratropium bromide solution is the first domestically-produced generic, presenting a favorable competitive landscape.
Chronic Disease Poverty Alleviation: Follow-up Support and Warmth
Time Posted：2019-05-31 09:40
To thoroughly implement the Party Central Committee's requirements for targeted poverty alleviation, strengthen efforts in targeted poverty alleviation, and ensure that poverty alleviation work is carried out effectively, recently, a team of six volunteers from the Healthy Yuan Volunteer Association, assisted by the local government and a charity association, went to Songpan County, Aba Tibetan and Qiang Autonomous Prefecture, Sichuan Province, to conduct follow-up work on the Healthy Yuan & Lizhu Pharmaceutical Group chronic disease poverty alleviation project.
Time Posted：2019-05-31 09:19
In the early morning of May 25, Beijing time, FTSE Russell, the world's second-largest index company, announced the first batch of A-shares to be included in its index system. This list includes large-cap, mid-cap, and small-cap stocks, with a total of 1097 A-shares selected, including Health and Medicine Group and Lizhu Group.
Jiankang Yuan Yi inhalation solution drug obtained registration approval
Time Posted：2019-05-29 11:03
Health Yuan announced on the evening of April 9 that its research drug, inhaled combined ipratropium bromide solution, has recently received the Drug Registration Certificate issued by the National Medical Products Administration. This drug, through the combined administration of ipratropium bromide and salbutamol sulfate, can simultaneously act on the muscarinic and β2-adrenergic receptors in the lungs, relaxing the smooth muscles of the respiratory tract from the main bronchi to the terminal bronchioles. It is suitable for patients who need the combined use of multiple bronchodilators, used to treat reversible bronchospasm related to airway obstructive diseases. Its efficacy is superior to single-drug administration, making it a clinical drug for patients with moderate to severe asthma and COPD. According to the announcement, as of that day, the total direct research and development costs for this drug were approximately 6.2384 million yuan. The announcement stated that currently, the only inhaled combined ipratropium bromide solution on the market in China is Boehringer Ingelheim's "Tiotropium Bromide." According to IQVIA data, the product's domestic sales in 2018 were approximately 343.44 million yuan. According to the website of the Center for Drug Evaluation of the National Medical Products Administration and the Xinda database, as of the date of the announcement, in addition to the original research product, only the company has obtained the registration certificate for this product. Another company has submitted a registration application for this product, which is currently under review and approval. (Huang Shu) Reprinted from: China Securities Journal
Time Posted：2019-05-29 10:35
Jiaozuo Healthy Element Bio-products Co., Ltd. 2018 Greenhouse Gas Emissions Verification Report
Time Posted：2019-05-29 10:05
Quick Navigation
+86 755-33268688 | Service Hotline
Official WeChat Official Account
Copyright © 2025 Joincare Pharmaceutical Group Industry Co., Ltd. ALL Rights Reserve.